| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919115 | Radiotherapy and Oncology | 2013 | 6 Pages |
Abstract
Good rates of biochemical control can be achieved in the medium term with BT monotherapy in IR disease. Raised iPSA correlated with a poorer outcome.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Anna Thi Huyen Tran, Paula Mandall, Ric Swindell, P.J. Hoskin, David Martin Bottomley, John Paul Logue, James Pinson Wylie,